Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration
Open Access
- 29 February 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Molecular Diagnostics
- Vol. 16 (5) , 513-520
Abstract
SummaryIt has been shown that in non-invasive prenatal testing (NIPT) there is a small chance of a false-positive or false-negative result. This is partly due to the fact that the fetal cell-free DNA present in maternal plasma is derived from the cytotrophoblast of chorionic villi (CV), which is not always representative for the fetal karyotype due to chromosomal mosaicism. Therefore, a positive NIPT result should always be confirmed with invasive testing, preferably amniocentesis, in order to investigate the fetal karyotype. However, since this invasive test can only be safely performed after 15.5 weeks of gestation while NIPT can be done from the 10th week of gestation, this potentially means an unacceptable long waiting time for the prospective parents to receive a definitive result. Based on our experience with cytogenetic investigations in CV and the literature, we determined whether CV sampling may be appropriate for confirmation of an abnormal NIPT result.Keywords
This publication has 44 references indexed in Scilit:
- False Negative NIPT Results: Risk Figures for Chromosomes 13, 18 and 21 Based on Chorionic Villi Results in 5967 Cases and Literature ReviewPLOS ONE, 2016
- Clinical implementation of NIPT – technical and biological challengesClinical Genetics, 2015
- Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysisUltrasound in Obstetrics & Gynecology, 2015
- Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy managementEuropean Journal of Human Genetics, 2015
- Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotypeUltrasound in Obstetrics & Gynecology, 2014
- Integration of Noninvasive DNA Testing for Aneuploidy into Prenatal Care: What Has Happened Since the Rubber Met the Road?Clinical Chemistry, 2014
- Secondary findings from non‐invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical servicePrenatal Diagnosis, 2013
- Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cellsExpert Opinion on Biological Therapy, 2012
- Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case reportHuman Reproduction, 2004
- Chromosomal Mosaicism Confined to the Placenta in Human ConceptionsScience, 1983